Wohl & Fruchter LLP Has Filed a Class Action Lawsuit on Behalf of Former Shareholders of Myovant Sciences, Ltd. in the U.S. District Court for the Southern District of New York MONSEY, N.Y., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Wohl & Fruchter LLP announces that on September 13, 2023, it filed a securities class action lawsuit in the United States District Court for the...

UROVANT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of UROV and Encourages Investors to Contact the Firm NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...

Sumitovant Biopharma Announces Urovant Sciences Collaboration with Sunovion Pharmaceuticals LONDON and NEW YORK, June 19, 2020 (GLOBE NEWSWIRE) -- Sumitovant Biopharma Ltd. today announced that Urovant Sciences (Nasdaq: UROV), a member of the Sumitovant Biopharma family of companies, has...